普拉德-威利综合征膳食纤维干预研究:对代谢与肠道菌群变化的启示
本研究采用自身对照交叉设计,14例普拉德-威利综合征(PWS)患者接受高剂量膳食纤维干预(35克/天)或对照各3周,洗脱期4至8周后交换方案。纤维干预未显著改善贪食或关键代谢指标,但改变了肠道菌群多样性并增加有益菌丰度,同时改变粪便和血清代谢物。作者建议进一步研究纤维干预的长期效果与潜在治疗应用。
要点
- 14例PWS患者对35克/天高纤维干预耐受性高,中位年龄13.6岁,女性8例(57.1%)。
- 纤维干预未显著改变贪食或关键代谢标志物,但改变了肠道菌群多样性并增加有益菌丰度。
- 纤维干预改变粪便和血清代谢物,包括支链脂肪酸减少和血清C4-OH酰基肉碱增加。
核心结论
- 本研究未观察到主要或次要终点有显著变化,但提示短期高纤维干预可能诱导PWS患者肠道菌群和微生物代谢物发生有益变化。
- 作者认为需要进一步研究纤维干预在PWS中的长期效果和潜在治疗应用。
研究设计与样本
- 自身对照交叉设计:参与者接受高剂量纤维干预(35克/天)或对照3周,洗脱期4至8周后交换治疗再3周。
- 共14例参与者,中位年龄13.6岁,女性8例(57.1%)。
- 每次治疗前后采集粪便(细菌16S核糖体RNA)和血液(免疫代谢标志物、靶向代谢组学)样本。
主要发现
- 14例参与者对纤维干预报告高度耐受。
- 纤维干预未显著改变贪食或关键代谢标志物。
- 纤维干预导致肠道菌群多样性变化,并增加有益菌丰度,如长双歧杆菌(Bifidobacterium longum)和普拉梭菌(Faecalibacterium prausnitzii)。
- 纤维干预改变粪便和血清代谢物,包括支链脂肪酸减少和血清C4-OH酰基肉碱增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: While increased fiber intake may benefit appetite and metabolism in the general population, its effects in individuals with Prader-Willi syndrome (PWS), a condition characterized by hyperphagia, obesity, and metabolic dysregulation, remain to be explored. OBJECTIVE: This study assessed the effects of a fiber intervention on hyperphagia, metabolic health, and gut microbiota in individuals with PWS, and explored associations between changes in health markers and shifts in microbiota. METHODS: Participants received either a high-dose fiber intervention (35 g/day) or a control for 3 weeks. Following a washout period of 4 to 8 weeks, participants switched treatments for another 3 weeks. Fecal (bacterial 16S ribosomal RNA) and blood (immunometabolic markers, targeted metabolomics) samples were collected before and after each treatment. RESULTS: Fourteen participants (with a median age of 13.6 years, 8 [57.1%] were female) reported high tolerance to the fiber intervention. While it did not significantly alter hyperphagia or key metabolic markers, the fiber intervention led to shifts in gut microbiota diversity and increased the abundance of beneficial bacteria, such as Bifidobacterium longum and Faecalibacterium prausnitzii. Additionally, it altered fecal and serum metabolites, including a decrease in branched-chain fatty acids and an increase in serum C4-OH acylcarnitine. CONCLUSION: While this study did not observe significant changes in primary or secondary endpoints, it suggests that a short-term high-fiber intervention may induce beneficial shifts in gut microbiota and microbial metabolites in individuals with PWS. Further research is warranted to investigate the long-term effects and potential therapeutic applications of fiber interventions in PWS.
引用
- Tan Q, Peng Y, Deehan EC, et al. Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts. J Clin Endocrinol Metab. 2025. PMID: 40036959. doi:10.1210/clinem/dgaf142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。